Literature DB >> 21487503

The SCHOOL of nature: IV. Learning from viruses.

Alexander B Sigalov1.   

Abstract

During the co-evolution of viruses and their hosts, the latter have equipped themselves with an elaborate immune system to defend themselves from the invading viruses. In order to establish a successful infection, replicate and persist in the host, viruses have evolved numerous strategies to counter and evade host antiviral immune responses as well as exploit them for productive viral replication. These strategies include those that modulate signaling mediated by cell surface receptors. Despite tremendous advancement in recent years, the exact molecular mechanisms underlying these critical points in viral pathogenesis remain unknown. In this work, based on a novel platform of receptor signaling, the Signaling Chain HOmoOLigomerization (SCHOOL) platform, I suggest specific mechanisms used by different viruses such as human immunodeficiency virus (HIV), cytomegalovirus (CMV), severe acute respiratory syndrome coronavirus, human herpesvirus 6 and others, to modulate receptor signaling. I also use the example of HIV and CMV to illustrate how two unrelated enveloped viruses use a similar SCHOOL mechanism to modulate the host immune response mediated by two functionally different receptors: T cell antigen receptor and natural killer cell receptor, NKp30. This suggests that it is very likely that similar general mechanisms can be or are used by other viral and possibly non-viral pathogens. Learning from viruses how to target cell surface receptors not only helps us understand viral strategies to escape from the host immune surveillance, but also provides novel avenues in rational drug design and the development of new therapies for immune disorders.

Entities:  

Year:  2010        PMID: 21487503      PMCID: PMC3062383          DOI: 10.4161/self.1.4.13279

Source DB:  PubMed          Journal:  Self Nonself        ISSN: 1938-2030


  224 in total

1.  HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.

Authors:  Francisco J Quintana; Doron Gerber; Sally C Kent; Irun R Cohen; Yechiel Shai
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

Review 2.  Toll-like receptors: linking innate and adaptive immunity.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

3.  Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement.

Authors:  David Fenard; Wes Yonemoto; Carlos de Noronha; Marielle Cavrois; Samuel A Williams; Warner C Greene
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

Review 4.  Innate recognition of viruses.

Authors:  Andreas Pichlmair; Caetano Reis e Sousa
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

Review 5.  The CD4 antigen: physiological ligand and HIV receptor.

Authors:  Q J Sattentau; R A Weiss
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

6.  The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function.

Authors:  Kirilee A Wilson; Séverine Bär; Anne L Maerz; Marc Alizon; Pantelis Poumbourios
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Authors:  Tal I Arnon; Hagit Achdout; Ofer Levi; Gal Markel; Nivin Saleh; Gil Katz; Roi Gazit; Tsufit Gonen-Gross; Jacob Hanna; Efrat Nahari; Angel Porgador; Alik Honigman; Bodo Plachter; Dror Mevorach; Dana G Wolf; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2005-04-10       Impact factor: 25.606

8.  Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6 u24 protein.

Authors:  Brian M Sullivan; Laurent Coscoy
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

9.  A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.

Authors:  Christina Paulus; Steffen Krauss; Michael Nevels
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-23       Impact factor: 11.205

10.  Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.

Authors:  N D Collins; G C Newbound; B Albrecht; J L Beard; L Ratner; M D Lairmore
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

View more
  4 in total

1.  Cells diversify transmembrane signaling through the controlled chaos of protein disorder.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2011-04-01

2.  SCHOOL of nature: ligand-independent immunomodulatory peptides.

Authors:  Alexander B Sigalov
Journal:  Drug Discov Today       Date:  2020-05-12       Impact factor: 7.851

3.  SARS Coronavirus Fusion Peptide-Derived Sequence Suppresses Collagen-Induced Arthritis in DBA/1J Mice.

Authors:  Zu T Shen; Alexander B Sigalov
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

Review 4.  Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old.

Authors:  Alexander B Sigalov
Journal:  Adv Protein Chem Struct Biol       Date:  2017-07-24       Impact factor: 3.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.